Literature DB >> 16682112

Atherosclerosis in women with endometriosis.

Stefano Pretta1, Valentino Remorgida, Luiza Helena Abbamonte, Paola Anserini, Nicola Ragni, Massimo Del Sette, Carlo Gandolfo, Simone Ferrero.   

Abstract

OBJECTIVE: This study aims to determine whether women with endometriosis have greater subclinical atherosclerosis than the general population. STUDY
DESIGN: This case-control study included 66 women with endometriosis and 66 controls matched for age and body mass index. All subjects were >or=35 years old. Exclusion criteria were obesity, diabetes, hypertension, hyperlipidemia, renal or metabolic diseases. Before laparoscopy, all patients underwent a measurement of intima-media thickness (IMT) and distensibility coefficient (DC) on the common carotid artery. In addition, blood samples were taken to determine the levels of lipids, fibrinogen, C-reactive protein, homocysteine, fasting glycemia, antithrombin III, plasminogen, protein C, protein S, and activated protein C resistance.
RESULTS: All the biochemical parameters evaluated had similar levels in the two study groups. IMT was similar in women with endometriosis and in controls both on left (p=0.330) and right (p=0.648) carotid artery. Similarly, no significant difference was observed in the DC between women with endometriosis and controls both on left (p=0.539) and right (p=0.178) carotid artery. No significant difference was observed in IMT and DC between women with mild and severe endometriosis.
CONCLUSION: Women with endometriosis do not have more subclinical atherosclerosis than the general population.

Entities:  

Mesh:

Year:  2006        PMID: 16682112     DOI: 10.1016/j.ejogrb.2006.04.015

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  8 in total

1.  Endometriosis and cardiovascular disease.

Authors:  Benjamin Marchandot; Anais Curtiaud; Kensuke Matsushita; Antonin Trimaille; Aline Host; Emilie Faller; Olivier Garbin; Chérif Akladios; Laurence Jesel; Olivier Morel
Journal:  Eur Heart J Open       Date:  2022-02-02

Review 2.  Endometriosis: a high-risk population for major chronic diseases?

Authors:  Marina Kvaskoff; Fan Mu; Kathryn L Terry; Holly R Harris; Elizabeth M Poole; Leslie Farland; Stacey A Missmer
Journal:  Hum Reprod Update       Date:  2015-03-11       Impact factor: 15.610

3.  Endometriosis and Risk of Coronary Heart Disease.

Authors:  Fan Mu; Janet Rich-Edwards; Eric B Rimm; Donna Spiegelman; Stacey A Missmer
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-03-29

4.  Long-term Health Consequences of Endometriosis - Pathways and Mediation by Treatment.

Authors:  Leslie V Farland; Holly R Harris
Journal:  Curr Obstet Gynecol Rep       Date:  2020-05-29

5.  A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis.

Authors:  Alexandra Vodolazkaia; Xavier Bossuyt; Amelie Fassbender; Cleophas M Kyama; Christel Meuleman; Karen Peeraer; Carla Tomassetti; Thomas M D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2011-08-09       Impact factor: 5.211

6.  There is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study.

Authors:  Felipe Barca Bragatto; Caio Parente Barbosa; Denise Maria Christofolini; Carla Peluso; Aline Amaro dos Santos; Fernanda Abani Mafra; Viviane Cavalcanti; Sonia Hix; Bianca Bianco
Journal:  Reprod Health       Date:  2013-06-22       Impact factor: 3.223

7.  Atherosclerosis-related biomarkers in women with endometriosis: The effects of dienogest and oral contraceptive therapy.

Authors:  Eiko Maeda; Akemi Koshiba; Taisuke Mori; Fumitake Ito; Hisashi Kataoka; Hiroyuki Okimura; Takuya Sugahara; Yosuke Tarumi; Izumi Kusuki; Khaleque N Khan; Jo Kitawaki
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2020-04-23

8.  A prospective study of endometriosis and risk of type 2 diabetes.

Authors:  Leslie V Farland; William J Degnan; Holly R Harris; Deirdre K Tobias; Stacey A Missmer
Journal:  Diabetologia       Date:  2021-01-05       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.